EUVIMEDEUVIMED entdecken
Crossref

Tirzepatide reduces body weight by increasing fat utilization via the central nervous system‐adipose tissue axis in male mice

Ailin Zhang, Qinhui Liu, Yimin Xiong, Jiahui Li, Ying Xu, Haiying Song, Xiandan Jing, Haixia Xu, Na Yang, Yanping Li, Li Mo, Qin Tang und 1 weitere

Diabetes, Obesity and Metabolism · 2025-05 · 27 (5) · 2844-2856

DOI: 10.1111/dom.16294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 25.02.2025. Verfasst von Ailin Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Adipose Tissue, Body Weight, Central Nervous System, Weight Loss. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation Group Project from Science & Technology Department of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Tirzepatide, a dual glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonist, demonstrates promise as a potent medication for obesity. However, the extent to which its weight‐reducing effects go beyond suppressing appetite remains unclear. This study aimed to elucidate this by establishing a pair‐fed control group, effectively eliminating the influence of reduced caloric intake. Materials and Methods Mice fed on a chow diet or a high‐fat diet received single or long‐term intracerebroventricular (i.c.v.) injections of tirzepatide or vehicle. The vehicle‐treated mice were pair‐fed to the tirzepatide‐treated group to avoid the impact induced by different caloric intakes. Body weight and food intake were monitored daily. Respiratory exchange ratio (RER) was determined in metabolic cages. Fat utilization was calculated based on RER. Parameters of lipid metabolism were evaluated.

Results

Mice receiving i.c.v. administration of tirzepatide exhibited significant reductions in body weight and fat content compared with pair‐fed controls. These effects were mediated by increased lipolytic capacity in white adipose tissue and enhanced thermogenesis in brown and beige adipose tissues, leading to decreased RER and increased lipid utilization. Mechanistic investigations revealed that these effects were primarily mediated by sympathetic nervous system innervation of adipose tissues. This innervation, in turn, might be associated with the neuronal activity changes in the dorsomedial hypothalamus and the nucleus of the solitary tract within the hindbrain.

Conclusions

These findings establish a critical role for tirzepatide in shifting the substrate preference to fat utilization through the central nervous system–adipose tissue axis, promoting weight loss independent of food intake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adipose TissueBody WeightCentral Nervous SystemWeight LossGlucagon-Like Peptide 1ObesityAnti-Obesity AgentsAnimalsMaleMiceDiet, High-FatMice, Inbred C57BLLipid MetabolismInjections, IntraventricularTirzepatide

Stichwörter der Autor:innen

GIPGLP‐1 analogueanimal pharmacologyantiobesity drug

Substanzen

Glucagon-Like Peptide 1Anti-Obesity AgentsTirzepatide

Autor:innen und Institutionen

  • West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China.
  • Department of Pharmacy, Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Center of Gerontology and Geriatrics, West China Hospital of Sichuan University, Chengdu, Sichuan, China.

ORCID-Profile: Jinhan He

Förderung

  • National Natural Science Foundation of China
  • Innovation Group Project from Science & Technology Department of Sichuan Province
  • National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University

Zitieren

APA

Zhang, A., Liu, Q., Xiong, Y., Li, J., Xu, Y., Song, H., Jing, X., Xu, H., Yang, N., Li, Y., Mo, L., Tang, Q., & He, J. (2025). Tirzepatide reduces body weight by increasing fat utilization via the central nervous system‐adipose tissue axis in male mice. Diabetes, Obesity and Metabolism, 27(5), 2844-2856. https://doi.org/10.1111/dom.16294

Vancouver

Zhang A, Liu Q, Xiong Y, Li J, Xu Y, Song H, et al. Tirzepatide reduces body weight by increasing fat utilization via the central nervous system‐adipose tissue axis in male mice. Diabetes, Obesity and Metabolism. 2025;27(5):2844-2856. doi:10.1111/dom.16294

BibTeX
@article{Zhang2025,
  author = {Zhang, Ailin and Liu, Qinhui and Xiong, Yimin and Li, Jiahui and Xu, Ying and Song, Haiying and Jing, Xiandan and Xu, Haixia and Yang, Na and Li, Yanping and Mo, Li and Tang, Qin and He, Jinhan},
  title = {Tirzepatide reduces body weight by increasing fat utilization via the central nervous system‐adipose tissue axis in male mice},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {5},
  pages = {2844--2856},
  doi = {10.1111/dom.16294}
}
Kostenlos starten →